Cortical Inhibition, Gamma-Aminobutyric Acid, and Major Depression: There Is Plenty of Smoke but Is There Fire?

Biological Psychiatry

Volumn 67, Issue 5, 2010, Pages 397-398

  Sanacora, Gerard ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; 4 AMINOBUTYRIC ACID RECEPTOR;

ARTICLE; BRAIN CORTEX; FRONTAL CORTEX; GABAERGIC SYSTEM; HUMAN; INTERNEURON; MAJOR DEPRESSION; NERVE EXCITABILITY; NEUROCHEMISTRY; NEUROIMAGING; NEUROPHYSIOLOGY; NEUROTRANSMISSION; NONHUMAN; OCCIPITAL CORTEX; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTON NUCLEAR MAGNETIC RESONANCE; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 75849155175     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2010.01.003     Document Type: Note

References (22)

1. Sanacora G., and Saricicek A. GABAergic contributions to the pathophysiology of depression and the mechanism of antidepressant action. CNS Neurol Disord Drug Targets 6 (2007) 127-140
2. Levinson A.J., Fitzgerald P.B., Favalli G., Blumberger D.M., Daigle M., and Daskalakis Z.J. Evidence of Cortical Inhibitory Deficits in Major Depressive Disorder. Biol Psychiatry 67 (2010) 458-464
3. Gold B., Bowers M.B., Roth R.H., and Sweeney D.W. GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry 137 (1980) 362-364
4. Petty F., and Schlesser M.A. Plasma GABA in affective illness. A preliminary investigation. J Affect Disord 3 (1981) 339-343
5. Sanacora G., Mason G.F., Rothman D.L., Behar K.L., Hyder F., Petroff O.A., et al. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 56 (1999) 1043-1047
6. Sanacora G., Gueorguieva R., Epperson C.N., Wu Y.-T., Appel M., Rothman D.L., et al. Subtype-specific alterations of GABA and glutamate in major depression. Arch Gen Psychiatry 61 (2004) 705-713
7. Hasler G., van der Veen J.W., Tumonis T., Meyers N., Shen J., and Drevets W.C. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Arch Gen Psychiatry 64 (2007) 193-200
8. Price R.B., Shungu D.C., Mao X., Nestadt P., Kelly C., Collins K.A., et al. Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: Relationship to treatment resistance in major depressive disorder. Biol Psychiatry 65 (2009) 792-800
9. Streeter C.C., Hennen J., Ke Y., Jensen J.E., Sarid-Segal O., Nassar L.E., et al. Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment. Psychopharmacology (Berl) 182 (2005) 516-526
10. Sanacora G., Mason G.F., Rothman D.L., Ciarcia J.J., Ostroff R.B., and Krystal J.H. Increased occipital cortex GABA concentrations following electroconvulsive therapy in depressed patients. Am J Psychiatry 160 (2003) 577-579
11. Sanacora G., Mason G.F., Rothman D.L., and Krystal J.H. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 159 (2002) 663-665
12. Bhagwagar Z., Wylezinska M., Taylor M., Jezzard P., Watthews P.M., and Cowen P.J. Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry 161 (2004) 368-370
13. Maciag D., Hughes J., O'Dwyer G., Pride Y., Stockmeier C.A., Sanacora G., et al. Reduced density of calbindin immunoreactive GABAergic neurons in the occipital cortex in major depression: Relevance to neuroimaging studies. Biol Psychiatry 67 (2009) 465-470
14. Unschuld P.G., Ising M., Specht M., Erhardt A., Ripke S., Heck A., et al. Polymorphisms in the GAD2 gene-region are associated with susceptibility for unipolar depression and with a risk factor for anxiety disorders. Am J Med Genet B Neuropsychiatr Genet 150B (2009) 1100-1109
15. Hettema J.M., An S.S., Neale M.C., Bukszar J., van den Oord E.J., Kendler K.S., et al. Association between glutamic acid decarboxylase genes and anxiety disorders, major depression, and neuroticism. Mol Psychiatry 11 (2006) 752-762
16. Alcaro A., Panksepp J., Witczak J., Hayes D.J., and Northoff G. Is subcortical-cortical midline activity in depression mediated by glutamate and GABA?. A cross-species translational approach. [published online ahead of print December 1]. Neurosci Biobehav Rev (2009)
17. Cryan J.F., and Kaupmann K. Don't worry "B" happy!: A role for GABA(B) receptors in anxiety and depression. Trends Pharmacol Sci 26 (2005) 36-43
18. Pilc A., and Nowak G. GABAergic hypotheses of anxiety and depression: Focus on GABA-B receptors. Drugs Today (Barc) 41 (2005) 755-766
19. Sequeira A., Mamdani F., Ernst C., Vawter M.P., Bunney W.E., Lebel V., et al. Global brain gene expression analysis links glutamatergic and GABAergic alterations to suicide and major depression. PLoS ONE 4 (2009) e6585
20. Klumpers U.M., Veltman D.J., Drent M.L., Boellaard R., Comans E.F., Meynen G., et al. Reduced parahippocampal and lateral temporal GABA(A)-[(11)C]flumazenil binding in major depression: Preliminary results. [published online ahead of print November 5]. Eur J Nucl Med Mol Imaging (2009)
21. Kucukibrahimoglu E., Saygin M.Z., Caliskan M., Kaplan O.K., Unsal C., and Goren M.Z. The change in plasma GABA, glutamine and glutamate levels in fluoxetine- or S-citalopram-treated female patients with major depression. Eur J Clin Pharmacol 65 (2009) 571-577
22. Golomb J.D., McDavitt J.R., Ruf B.M., Chen J.I., Saricicek A., Maloney K.H., et al. Enhanced visual motion perception in major depressive disorder. J Neurosci 29 (2009) 9072-9077